PA
PAHC
Market ClosedPhibro Animal Health Corporation
US
2.60K employees
CEO: Daniel Bendheim
Founded: 2014
$35.62
+$0.00(+NaN%)
Market Cap
1.44B
Beta
0.47
52W Range
N/A
Dividend Yield
1.35%
Forecasting Analysis
AI-powered predictions and statistical risk modeling for short-term price movements
AI Insight:
Phibro Animal Health's AI-driven 30-day forecast is trending modestly higher, indicating near-term positive momentum. Analyst consensus over 12 months is strongly covered with tight agreement, signaling broad alignment on upside potential. This convergence and consistent positive outlook reduce perceived uncertainty, implying lower investment risk.
Current Price
N/A
Last closing price
Price Prediction
Machine learning prediction based on historical price patterns
Period:
Analyst Price Target for PAHC
Loading analyst price targets...
Wall Street Forecasts
Revenue Forecast
Past Growth
N/A
Based on Historical CAGR
Forward Growth
N/A
Projected CAGR
Analyst Accuracy
0%
Estimate Accuracy
Revenue Analysis
Comparison of Actual and Estimated Revenues
Loading chart data...
Revenue growth steady at 0.0%.
Operating Profitability Forecast
Past Growth
N/A
EBITDA Historical CAGR
Forward Growth
N/A
EBITDA Projected CAGR
Analyst Accuracy
0%
Estimate Accuracy
EBITDA Analysis
Comparison of Actual and Estimated EBITDA
Loading chart data...
EBITDA maintaining 0.0% trajectory.
Earnings Per Share Forecast
Past Growth
N/A
EPS Historical CAGR
Forward Growth
N/A
EPS Projected CAGR
Analyst Accuracy
0%
Estimate Accuracy
EPS Analysis
Comparison of Actual and Estimated Earnings Per Share
Loading chart data...
EPS growth stable around 0.0%.
Explore PAHC
PAHC in the Healthcare
Small Cap